Aytu Biopharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.32

-0.01 (-0.43%)

As of Aug 8, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +294.4% upside

Low Target $5.34

Average Target $9.15

High Target $10.98

Current Price $2.32

Current
$2.32

Target
$9.15

$5.34 $9.15 avg $10.98

Scenario Analysis

Bear Case

$5.34

130.2%

Low target

Base Case

$9.15

+294.4%

Avg target

Bull Case

$10.98

+373.3%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$3.07

-24.3% from high

52-Week Low

$1.65

+40.6% from low

Target vs 52W High

$9.15

+198.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%